Higashi K et al. |
Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts. |
2016 |
Bone |
pmid:27612439
|
Bougault C et al. |
Involvement of sphingosine kinase/sphingosine 1-phosphate metabolic pathway in spondyloarthritis. |
2017 |
Bone |
pmid:28684192
|
Sabbadini RA |
Targeting sphingosine-1-phosphate for cancer therapy. |
2006 |
Br. J. Cancer |
pmid:17024123
|
Nunes J et al. |
Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. |
2012 |
Br. J. Cancer |
pmid:22315056
|
Amano S et al. |
Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. |
2004 |
Br. J. Dermatol. |
pmid:15541073
|
Yang L et al. |
Metabolism and functional effects of sphingolipids in blood cells. |
1999 |
Br. J. Haematol. |
pmid:10583213
|
Shayegi N et al. |
CXCR4 blockade and sphingosine-1-phosphate activation facilitate engraftment of haematopoietic stem and progenitor cells in a non-myeloablative transplant model. |
2014 |
Br. J. Haematol. |
pmid:24180707
|
Koresawa R et al. |
Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma. |
2016 |
Br. J. Haematol. |
pmid:27061580
|
Wallington-Beddoe CT et al. |
Oncogenic properties of sphingosine kinases in haematological malignancies. |
2013 |
Br. J. Haematol. |
pmid:23521541
|
Harvey KA et al. |
Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. |
2008 |
Br. J. Nutr. |
pmid:17925051
|
Koch A et al. |
Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells. |
2012 |
Br. J. Pharmacol. |
pmid:22221312
|
Schuchardt M et al. |
Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. |
2011 |
Br. J. Pharmacol. |
pmid:21309759
|
Roviezzo F et al. |
S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms. |
2015 |
Br. J. Pharmacol. |
pmid:25439580
|
Lindner K et al. |
Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. |
2005 |
Br. J. Pharmacol. |
pmid:15735657
|
Sabbadini RA |
Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. |
2011 |
Br. J. Pharmacol. |
pmid:21091645
|
Alewijnse AE and Michel MC |
Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? |
2006 |
Br. J. Pharmacol. |
pmid:16402045
|
Mathieson FA and Nixon GF |
Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation. |
2006 |
Br. J. Pharmacol. |
pmid:16402047
|
Igarashi J et al. |
Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. |
2007 |
Br. J. Pharmacol. |
pmid:17220911
|
Tran-Dinh A et al. |
HDL and endothelial protection. |
2013 |
Br. J. Pharmacol. |
pmid:23488589
|
Nixon GF |
Sphingolipids in inflammation: pathological implications and potential therapeutic targets. |
2009 |
Br. J. Pharmacol. |
pmid:19563535
|
Bischoff A et al. |
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. |
2000 |
Br. J. Pharmacol. |
pmid:10952677
|
Bischoff A et al. |
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. |
2000 |
Br. J. Pharmacol. |
pmid:10952678
|
Alewijnse AE et al. |
Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. |
2004 |
Br. J. Pharmacol. |
pmid:15504747
|
Sykes DA et al. |
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization. |
2014 |
Br. J. Pharmacol. |
pmid:24641481
|
Xin C et al. |
Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells. |
2004 |
Br. J. Pharmacol. |
pmid:15466446
|
Brailoiu E et al. |
Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction. |
2002 |
Br. J. Pharmacol. |
pmid:12163341
|
McDonald RA et al. |
The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia. |
2010 |
Br. J. Pharmacol. |
pmid:20015089
|
Mair KM et al. |
Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery. |
2010 |
Br. J. Pharmacol. |
pmid:20718749
|
Brinkmann V |
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. |
2009 |
Br. J. Pharmacol. |
pmid:19814729
|
Kurano M et al. |
Resveratrol exerts a biphasic effect on apolipoprotein M. |
2016 |
Br. J. Pharmacol. |
pmid:26445217
|
Hsu CK et al. |
Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. |
2015 |
Br. J. Pharmacol. |
pmid:26359950
|
Majeed Y et al. |
Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids. |
2011 |
Br. J. Pharmacol. |
pmid:21108630
|
Jongsma M et al. |
Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). |
2009 |
Br. J. Pharmacol. |
pmid:19309361
|
Salomone S et al. |
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. |
2008 |
Br. J. Pharmacol. |
pmid:18026125
|
Hemmings DG et al. |
Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. |
2004 |
Br. J. Pharmacol. |
pmid:15326035
|
Lim KG et al. |
Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival. |
2012 |
Br. J. Pharmacol. |
pmid:22251058
|
Camaré C et al. |
Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody. |
2015 |
Br. J. Pharmacol. |
pmid:25176316
|
Serdar M et al. |
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. |
2016 |
Brain Behav. Immun. |
pmid:26456693
|
Yamamura T |
[Molecular target drug development for curing multiple sclerosis]. |
2009 |
Brain Nerve |
pmid:19697881
|
Shinpo K et al. |
Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. |
1999 |
Brain Res. |
pmid:10082875
|
Rao TS et al. |
Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. |
2003 |
Brain Res. |
pmid:14568343
|
Attiori Essis S et al. |
GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P. |
2015 |
Brain Res. |
pmid:26260438
|
Sato K et al. |
Sphingosine 1-phosphate induces expression of early growth response-1 and fibroblast growth factor-2 through mechanism involving extracellular signal-regulated kinase in astroglial cells. |
1999 |
Brain Res. Mol. Brain Res. |
pmid:10640689
|
Sato K et al. |
Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells. |
2000 |
Brain Res. Mol. Brain Res. |
pmid:11146117
|
Segura BJ et al. |
Sphingosine-1-phosphate induces early response gene expression in C6 glioma cells. |
2005 |
Brain Res. Mol. Brain Res. |
pmid:15710251
|
Spiegel S et al. |
Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells. |
1994 |
Breast Cancer Res. Treat. |
pmid:7881110
|
Ruckhäberle E et al. |
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. |
2008 |
Breast Cancer Res. Treat. |
pmid:18058224
|
Pchejetski D et al. |
Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. |
2010 |
Breast Cancer Res. Treat. |
pmid:20535545
|
Serebrov VY et al. |
Functional activity of sphingomyelin cycle in rat liver in chronic toxic hepatitis. |
2008 |
Bull. Exp. Biol. Med. |
pmid:19513367
|
Liu X et al. |
Effect of sphingosine 1-phosphate on morphological and functional responses in endothelia and venules after scalding injury. |
2009 |
Burns |
pmid:19520517
|